Paper40046366
Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.
Miyaishi M and 4 others. Cureus, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa. Papers, record 40046366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40046366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30553196 | Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30553196 | PubMed |
| 2 | 17689125 | Glycogen storage disease type IX: High variability in clinical phenotype. | Mol Genet Metab | 2007 | https://conductscience.org/library/papers/17689125 | PubMed |
| 3 | 26965985 | Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis. | Drug Metab Dispos | 2016 | https://conductscience.org/library/papers/26965985 | PubMed |
| 4 | 32505569 | Liver histology in children with glycogen storage disorders type VI and IX. | Dig Liver Dis | 2021 | https://conductscience.org/library/papers/32505569 | PubMed |
| 5 | 32633407 | Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32633407 | PubMed |
| 6 | 33342284 | Post-treatment with glycyrrhizin can attenuate hepatic mitochondrial damage induced by acetaminophen in mice. | Exp Biol Med (Maywood) | 2021 | https://conductscience.org/library/papers/33342284 | PubMed |
| 7 | 14767974 | Apoptosis: the nexus of liver injury and fibrosis. | Hepatology | 2004 | https://conductscience.org/library/papers/14767974 | PubMed |
| 8 | 23578772 | Aggressive therapy improves cirrhosis in glycogen storage disease type IX. | Mol Genet Metab | 2013 | https://conductscience.org/library/papers/23578772 | PubMed |
| 9 | 21646031 | Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. | Mol Genet Metab | 2011 | https://conductscience.org/library/papers/21646031 | PubMed |
| 10 | 28317891 | Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa). | Sci Rep | 2017 | https://conductscience.org/library/papers/28317891 | PubMed |
| 11 | 17514432 | A novel starch for the treatment of glycogen storage diseases. | J Inherit Metab Dis | 2007 | https://conductscience.org/library/papers/17514432 | PubMed |
| 12 | 31665208 | Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies. | Adv Nutr | 2020 | https://conductscience.org/library/papers/31665208 | PubMed |
| 13 | 33317799 | Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX. | Mol Genet Metab | 2020 | https://conductscience.org/library/papers/33317799 | PubMed |
| 14 | 36817397 | Interleukin 25 and its biological features and function in intestinal diseases. | Cent Eur J Immunol | 2022 | https://conductscience.org/library/papers/36817397 | PubMed |
| 15 | 30659246 | Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2019 | https://conductscience.org/library/papers/30659246 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PHKA2 | 5256 | PubTator's text mining | https://conductscience.org/library/genes/5256 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40046366
GET https://conductscience.org/api/papers/v1/40046366/authors